Nothing Special   »   [go: up one dir, main page]

About: Guerbet

An Entity of Type: company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Guerbet (Euronext: GBT) is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent. In 2017 Guerbet’s revenues were €807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in France, Ireland, Canada, Macedonia, the United States and Brazil. The company’s headquarters are located in Villepinte, a suburb of Paris and its shares are included in the CAC Small stock index.

Property Value
dbo:abstract
  • Guerbet ist ein auf Kontrastmittel spezialisiertes Pharmaunternehmen mit Sitz in Villepinte, nordöstlich von Paris. Das Unternehmen beschäftigt nach eigenen Angaben weltweit etwa 2700 Mitarbeiter und ist im CAC Small gelistet. (de)
  • Guerbet (Euronext: GBT) is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent. In 2017 Guerbet’s revenues were €807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in France, Ireland, Canada, Macedonia, the United States and Brazil. The company’s headquarters are located in Villepinte, a suburb of Paris and its shares are included in the CAC Small stock index. In July 2015, Guerbet announced the takeover of Mallinckrodt's contrast media and application systems divisions. The acquisition was completed in November 2015. (en)
  • Guerbet est une entreprise pharmaceutique française créée en 1926. Elle est cotée à la bourse de Paris. (fr)
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 13706713 (xsd:integer)
dbo:wikiPageLength
  • 1585 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1100304005 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dbp:wordnet_type
dct:subject
gold:hypernym
schema:sameAs
rdf:type
rdfs:comment
  • Guerbet ist ein auf Kontrastmittel spezialisiertes Pharmaunternehmen mit Sitz in Villepinte, nordöstlich von Paris. Das Unternehmen beschäftigt nach eigenen Angaben weltweit etwa 2700 Mitarbeiter und ist im CAC Small gelistet. (de)
  • Guerbet est une entreprise pharmaceutique française créée en 1926. Elle est cotée à la bourse de Paris. (fr)
  • Guerbet (Euronext: GBT) is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent. In 2017 Guerbet’s revenues were €807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in France, Ireland, Canada, Macedonia, the United States and Brazil. The company’s headquarters are located in Villepinte, a suburb of Paris and its shares are included in the CAC Small stock index. (en)
rdfs:label
  • Guerbet (de)
  • Guerbet (en)
  • Guerbet (fr)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License